Back to results
US 7,612,050 B2Granted
Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
AssigneeThe Royal Alexandra Hospital for Children
InventorsDavid Graham Little, Nicholas Charles Smith
Life of this patent
Estimating the term…
Abstract
A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further he used to prevent the onset of osteonecrosis and/or osetonecrosis dissecans and any complications associated with both diseases.
Claims28
A method of treating a patient with osteonecrosis, the method comprising:
- administering to the patient a drug consisting of at least one bisphosphonate or any pharmaceutically acceptable salt, hydrate or ester thereof.
Dependencies are inferred from the claim text.